Stuart Donaldson

Stuart Donaldson is currently serving as the Sr. Director and Global Head of Clinical Data Management at Nestlé Health Science since November 2020, following the acquisition of Aimmune Therapeutics. Prior to this role, Stuart held the position of Sr. Director of Clinical Data Management at Aimmune Therapeutics from May 2017 to November 2020, where leadership of the Clinical Data Management team was provided for the pivotal Palforzia trials that led to regulatory approvals in the US and Europe. Stuart's extensive career began at Genentech, serving as Head of gRED Clinical Data Management from January 1995 to 2017, and included a role as Supervisor of Data Management at Applied Immune Sciences, Rhone-Poulenc Rorer from 1992 to 1994. Education includes a Bachelor’s Degree in Evolutionary Biology from the University of California, Berkeley, and a Master of Public Health in Epidemiology from San Diego State University.